Cytokinetics Inc. buy UBS Group AG
Start price
03.04.23
/
50%
€34.60
Target price
03.04.24
€56.02
Performance (%)
87.86%
End price
04.04.24
€65.00
Summary
This prediction ended on 04.04.24 with a price of €65.00. With a performance of 87.86% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytokinetics Inc. | 5.079% | 5.079% | 153.521% | 133.766% |
| iShares Core DAX® | -1.358% | -2.165% | 2.078% | 52.680% |
| iShares Nasdaq 100 | -3.700% | -1.162% | 32.596% | 88.748% |
| iShares Nikkei 225® | -2.512% | 7.930% | 58.269% | 82.315% |
| iShares S&P 500 | -1.662% | -0.698% | 22.962% | 66.078% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at UBS Group AG from $67.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten